MedPath

DICLOFENAC POTASSIUM

These highlights do not include all the information needed to use Diclofenac Potassium safely and effectively. See full prescribing information for Diclofenac Potassium. Diclofenac Potassium powder, for oral solution Initial U.S. Approval: 1988

Approved
Approval ID

9dd418b2-4b0e-498c-b453-f580c69ddc6d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2024

Manufacturers
FDA

Leading Pharma, LLC

DUNS: 079575060

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DICLOFENAC POTASSIUM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69315-506
Application NumberNDA022165
Product Classification
M
Marketing Category
C73605
G
Generic Name
DICLOFENAC POTASSIUM
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 4, 2024
FDA Product Classification

INGREDIENTS (5)

DICLOFENAC POTASSIUMActive
Quantity: 50 mg in 1 1
Code: L4D5UA6CB4
Classification: ACTIB
GLYCERYL DIBEHENATEInactive
Code: R8WTH25YS2
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT
POTASSIUM BICARBONATEInactive
Code: HM5Z15LEBN
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DICLOFENAC POTASSIUM - FDA Drug Approval Details